Clinical Trials Sponsored by Enyo Pharma

Total 8485 results

Enyo Pharma

Completed

Safety, Tolerability, Pharmacokinetics and Efficacy of EYP001a in Patients With Nonalcoholic Steatohepatitis (NASH)

Non-alcoholic Steatohepatitis

United States, Belgium, France, Puerto Rico, United Kingdom
Enyo Pharma

Completed

A Study of the Oral Farnesoid X Receptor Modulator EYP001a to Assess Its Safety and Anti-viral Effect in Chronic Hepatitis B Patients in Combination With Pegylated Interferon alpha2a Alone and With Entecavir

Hepatitis B, Chronic

Hong Kong, Korea, Republic of, Taiwan
Enyo Pharma

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of EYP001a in Healthy Volunteers and Nonalcoholic Steatohepatitis Patients

Healthy | NASH - Nonalcoholic Steatohepatitis

Australia
Enyo Pharma

Completed

Mass Balance Study to Investigate the Absorption, Metabolism and Excretion of [14C]-EYP001a After a Single Oral Dose

Healthy

Netherlands
Enyo Pharma
PRA Health Sciences

Completed

EYP001a Food Effect Study in Subjects With Chronic Hepatitis B Virus (HBV) Infection

Hepatitis B, Chronic

Netherlands
Enyo Pharma
PRA Health Sciences

Completed

Study Evaluating Safety, Tolerability and Pharmacokinetics of EYP001a in Healthy Male Subjects

Healthy
Enyo Pharma
CPR Pharma Services Pty Ltd, Australia

Completed

Drug Drug Interaction Study for EYP001 With Entecavir

Hepatitis B, Chronic

Australia
Enyo Pharma
CPR Pharma Services Pty Ltd, Australia

Completed

Evaluation of the Safety and Pharmacology of EYP001 in HBV Subjects

Hepatitis B, Chronic

Thailand, Netherlands, Australia, Poland
ZARS Pharma Inc.
Endo Pharmaceuticals

Completed

Evaluate the Depth and Duration of Anesthesia

Pain

United States
Orion Corporation, Orion Pharma
Endo Pharmaceuticals

Completed

Bioavailability Study of ODM-201 in Subjects With Metastatic Chemotherapy-naive Castration-resistant Prostate Cancer (ARAFOR)

Prostate Cancer

Latvia
Orion Corporation, Orion Pharma
Endo Pharmaceuticals

Completed

Safety and Pharmacokinetics Study of ODM-201 in Castrate Resistant Prostate Cancer

Prostate Cancer

United States, United Kingdom, Finland, France, Czech Republic, Estonia
Enyo Pharma
Parexel; Novotech (Australia) Pty Limited; Synteract, Inc.; Eurofins

Terminated

Study of EYP001a to Assess Its Safety and Anti-viral Effect in CHB Patients in Combination With NA (ETV or TD)

Hepatitis B, Chronic

Australia, Hong Kong, Korea, Republic of, Poland
Endo Pharmaceuticals

Completed

Study to Evaluate Efficacy and Safety of Histrelin Subdermal Implant in Men With Advanced Prostate Cancer

Prostate Cancer | Adenocarcinoma of the Prostate
Endo Pharmaceuticals

Completed

Topical Lidocaine Patch in Low Back Pain

Acute and Chronic Non-radicular LBP

United States
Endo Pharmaceuticals

Completed

A Study Of Lidocaine Patch 5% Alone, Gabapentin Alone, And Lidocaine Patch 5% And Gabapentin In Combination For The Relief Of Pain In Patients With Diverse Peripheral Neuropathic Pain Conditions

Carpal Tunnel Syndrome | Complex Regional Pain Syndrome | Peripheral Neuropathy | Diabetic Neuropathy | Postherpetic Neuralgia | HIV Neuropathy | Idiopathic Sensory Neuropathy

United States
Endo Pharmaceuticals

Completed

Long-Term Study of EN3835 (CCH-aaes) in Edematous Fibrosclerotic Panniculopathy (Cellulite)

Cellulite | Edematous Fibrosclerotic Panniculopathy

United States
Endo Pharmaceuticals

Completed

Injection Techniques of Collagenase Clostridium Histolyticum (CCH) for the Treatment of EFP (Cellulite)

Edematous Skin

United States
Endo Pharmaceuticals

Completed

A Study of the Effect of Testosterone Replacement Therapy on Blood Pressure in Adult Male Participants With Hypogonadism

Hypogonadotropic Hypogonadism | Hypogonadism | Hypogonadism, Male

United States
Endo Pharmaceuticals

Terminated

Long-term Follow-up Durability (Efficacy) Study of EN3835 for the Treatment of AC of the Shoulder (Frozen Shoulder)

Adhesive Capsulitis | Frozen Shoulder

United States
Endo Pharmaceuticals

Completed

CCH Treatment of Cellulite in the Presence of Dermal Laxity With Comparison Between Two (2) Different Injection Techniques

Laxity; Skin | Cellulite | Edematous Fibrosclerotic Panniculopathy

United States
Endo Pharmaceuticals

Completed

Real World CCH Study in Adult Females With Cellulite

Cellulite | Edematous Fibrosclerotic Panniculopathy (EFP)

United States, Puerto Rico
Endo Pharmaceuticals

Completed

Safety and Pharmacokinetics of Vasopressin in Healthy Volunteers

Healthy Volunteer Safety Study

United States
Endo Pharmaceuticals

Completed

Effectiveness and Safety of EN3835 in the Treatment of Cellulite in Women (RELEASE-2)

Edematous Fibrosclerotic Panniculopathy (Cellulite)

United States
Endo Pharmaceuticals

Completed

Durability and Safety of EN3835 in the Treatment of EFP (Cellulite) in Women

Edematous Fibrosclerotic Panniculopathy

United States
Endo Pharmaceuticals

Completed

Long-term Safety, Curvature Deformity Characterization, and Immunogenicity Over Time in Subjects Previously Treated With AA4500 for Peyronies Disease

Peyronie's Disease

United States
Endo Pharmaceuticals

Completed

Non-US Study of AA4500 (XIAFLEX™, Proposed Name) in the Treatment of Advanced Dupuytren's Disease (CORD-II)

Advanced Dupuytren's Disease

Australia
Endo Pharmaceuticals

Completed

A Study of AA4500 in Men With Peyronie's Disease

Peyronie's Disease

United States, Denmark, France, Germany, Italy, New Zealand, Spain, Sweden, United Kingdom
Endo Pharmaceuticals

Terminated

Multi-center Study to Evaluate the Efficacy and Safety of Maintenance Therapy With Valrubicin Versus no Maintenance, in Subjects Treated With Valrubicin Induction for Carcinoma in Situ (CIS) of the Bladder

Carcinoma in Situ | Transitional Cell Carcinoma | Non-muscle Invasive Bladder Cancer

United States
Endo Pharmaceuticals

Completed

Study of AA4500 in the Treatment of Peyronie's Disease

Peyronie's Disease

United States, Australia
Endo Pharmaceuticals

Completed

Safety and Efficacy of Two Concurrent Injections of AA4500 in Adult Subjects With Multiple Dupuytren's Contractures

Dupuytren's Contracture

United States
Endo Pharmaceuticals

Completed

A Study of Fortigel Testosterone Gel 2% in Males With Low Testosterone

Hypogonadism
Endo Pharmaceuticals

Completed

Phase 2a Dose-Ranging Study to Evaluate Safety and Effectiveness of AA4500 in Treatment of Dupuytren's Disease Nodules

Dupuytren's Disease

United States, Australia
Endo Pharmaceuticals

Completed

Intravesical AD 32 (Valrubicin) in Patients With Carcinoma in Situ (CIS) of the Bladder Who Have Failed or Have Recurrence Following Treatment With Bacillus Calmette-guerin (BCG) (Bladder Cancer)

Carcinoma in Situ | Bladder Cancer

United States
Endo Pharmaceuticals

Completed

Study in Stabilized Schizophrenic Patients to Evaluate the Pharmacokinetics of Risperidone and 9-Hydroxy (OH)-Risperidone When Risperidone is Administered From a Polyurethane Implant

Schizophrenia

United States
Endo Pharmaceuticals

Completed

A Study Comparing The Efficacy And Safety Of Lidocaine 5% Patch With Placebo In Patients With Chronic Axial Low Back Pain

Chronic Low Back Pain

United States
Endo Pharmaceuticals

Completed

EXPRESS: Examining Pagoclone for Persistent Developmental Stuttering Study

Persistent Developmental Stuttering

United States
Endo Pharmaceuticals

Completed

Open Label Study of Octreotide Implant in Patients With Acromegaly

Acromegaly
Endo Pharmaceuticals

Terminated

Safety and Efficacy of Lidoderm (Lidocaine Patch 5%) in Treating Moderate to Severe Pain Associated With Carpal Tunnel Syndrome

Carpal Tunnel Syndrome

United States
Endo Pharmaceuticals

Completed

Post-operative Efficacy and Safety Study

Post-operative Pain
Endo Pharmaceuticals

Completed

Oxymorphone Extended Release (ER) in Opioid-Naive Patients With Chronic Pain

Pain | Chronic Disease
R-Pharm
Covance; Cromos Pharma LLC

Withdrawn

Study of the Efficacy and Safety of a Single Administration of Olokizumab vs. Placebo in Addition to Standard Treatment in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19).

COVID-19
Endo Pharmaceuticals

Terminated

Real-World Data Study to Understand Effectiveness of Treatments in Peyronie's Disease (CURVE-PD)

Peyronie's Disease

United States
Endo Pharmaceuticals

Completed

Long-term Durability Study of Collagenase Clostridium Histolyticum (CCH)

Edematous Fibrosclerotic Panniculopathy

United States
Endo Pharmaceuticals

Completed

Efficacy and Safety of Oxymorphone Immediate Release in Post-surgical Acute Pain

Acute Pain

United States
Endo Pharmaceuticals

Completed

A Controlled Trial to Investigate the Efficacy and Safety of Frovatriptan to Prevent Menstrual Migraine

Migraine
Endo Pharmaceuticals

Completed

Safety and Efficacy of EN3835 in Participants With Frozen Shoulder

Adhesive Capsulitis | Frozen Shoulder

United States
Endo Pharmaceuticals

Completed

Durability and Safety of CCH With Two Different Injection Techniques in Cellulite With Laxity

Laxity; Skin | Cellulite | Edematous Fibrosclerotic Panniculopathy

United States
Endo Pharmaceuticals

Terminated

Clinical Study to Evaluate the Effectiveness, Safety, and Tolerability of Oxymorphone Immediate Release (IR) Oral Liquid in Post Surgical Pediatric Subjects

Acute Pain | Post-Operative Pain

United States
Endo Pharmaceuticals

Terminated

Impact of CCH Treatment of Buttock and Thigh Cellulite in Adult Women

Cellulite | Edematous Fibrosclerotic Panniculopathy (EFP)

United States
Endo Pharmaceuticals

Completed

Histrelin Subcutaneous Implant in Children With Central Precocious Puberty

Central Precocious Puberty

3

Subscribe